Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, there are currently no effective drugs targeting 2019-nCoV/SARS-CoV-2. D...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cell discovery 2020-03, Vol.6 (1), p.14, Article 14
Hauptverfasser:	Zhou, Yadi, Hou, Yuan, Shen, Jiayu, Huang, Yin, Martin, William, Cheng, Feixiong
Format:	Artikel
Sprache:	eng
Schlagworte:	6-Mercaptopurine 631/1647/2067 631/1647/2217/748 631/1647/48 Antiviral agents Biomedical and Life Sciences Cell Biology Cell Culture Cell Cycle Analysis Cell lines Cell Physiology Conserved sequence Coronaviridae Coronaviruses COVID-19 Dactinomycin Drug delivery Drug development Drug discovery Drugs Emodin Genomes Life Sciences Melatonin Morbidity Nucleocapsids Nucleotide sequence Phylogeny Rapamycin Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Stem Cells Therapeutic targets Toremifene
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!